Oakland Colon Rectal Associates
Royal Oak, Michigan, United States
Association in Royal Oak, Michigan
1121 Crooks Rd, Royal Oak, MI 48067
About Oakland Colon Rectal Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
17
Alliance for Clinical Trials in Oncology
11
SWOG Cancer Research Network
10
ECOG-ACRIN Cancer Research Group
5
NRG Oncology
2
Eisai Inc.
1
Clinical Trials at Oakland Colon Rectal Associates
During the past decade, Oakland Colon Rectal Associates conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 18 clinical trials were completed, i.e. on
average, 72% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 16 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy
2006-03-01
2006-10-01
Completed
300
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
2010-06-01
Active, not recruiting
2,527
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
2012-08-08
2027-07-19
Active, not recruiting
129
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
2013-12-02
2034-02-05
Active, not recruiting
1,087
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2013-12-09
2024-01-19
Active, not recruiting
547
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
2014-02-07
Active, not recruiting
2,012
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Oakland Colon Rectal Associates" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "Alliance for Clinical Trials in Oncology" with 11 trials
sponsored, "SWOG Cancer Research Network" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NRG Oncology"
with 5 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oakland Colon Rectal Associates"
#1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Oakland Colon Rectal Associates
According to Clinical.Site data, the most researched conditions in "Oakland Colon Rectal Associates" are
"Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Stage IIIA Breast Cancer" (5 trials), "Stage II Breast Cancer" (4 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "Oakland Colon Rectal Associates" in a lesser frequency.
Clinical Trials Intervention Types at Oakland Colon Rectal Associates
Most popular intervention types in "Oakland Colon Rectal Associates" are "Other" (38 trials), "Drug" (36 trials), "Biological" (14 trials), "Procedure" (13 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (16 trials), "Questionnaire Administration" (8 trials), "Computed Tomography" (7 trials) and "Biospecimen Collection" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Oakland Colon Rectal Associates
The vast majority of trials in "Oakland Colon Rectal Associates" are
42 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Oakland Colon Rectal Associates
Currently, there are NaN active trials in "Oakland Colon Rectal Associates".
undefined are not yet recruiting,
8 are recruiting,
27 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Oakland Colon Rectal Associates,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Oakland Colon Rectal Associates, 0 "Phase 1"
clinical trials were conducted, 17 "Phase 2" clinical
trials and 30 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".